Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Withings Hypertension Notification Retrospective Study

NCT: NCT07631715 · ACTIVE_NOT_RECRUITING

NCT IDNCT07631715
StatusACTIVE_NOT_RECRUITING
Start Date2026-03-01
Completion2026-07
SponsorWithings (INDUSTRY)
First posted
Last updated

Brief Summary

This retrospective, non-interventional clinical investigation evaluates the diagnostic performance of the Withings Hypertension Notification Feature (HTNF), a software-only medical device (SaMD) that analyzes demographic, anthropometric, and physiological parameters collected by Withings connected smart scales to identify patterns suggestive of hypertension. Ground-truth blood pressure measurements are obtained concurrently from Withings connected blood pressure monitors.

Frequently Asked Questions

What is Withings Hypertension Notification Retrospective Study?

Withings Hypertension Notification Retrospective Study is a clinical trial registered under NCT07631715. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07631715?

The current status of NCT07631715 (Withings Hypertension Notification Retrospective Study) is: ACTIVE_NOT_RECRUITING.

When did Withings Hypertension Notification Retrospective Study start?

Withings Hypertension Notification Retrospective Study started on 2026-03-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.